{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:14:56Z","timestamp":1784657696390,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kenyatta National Hospital (KNH) Medical Research and Programs","award":["KNH\/R&P\/23K\/23\/6"],"award-info":[{"award-number":["KNH\/R&P\/23K\/23\/6"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bacterial infections are a common complication in patients with seasonal viral respiratory tract infections and are associated with poor prognosis, increased risk of intensive care unit admission and 29\u201355% mortality. Yet, there is limited data on the burden of bacterial infections among COVID-19 patients in Africa, where underdeveloped healthcare systems are likely to play a pertinent role in the epidemiology of the COVID-19 pandemic. Here, we evaluated the etiologies, antimicrobial resistance profiles, risk factors, and outcomes of bacterial infections in severely ill COVID-19 patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A descriptive cross-sectional study design was adopted in severely ill COVID-19 patients at Kenyatta National Hospital, Kenya, from October to December 2021. We used a structured questionnaire and case report forms to collect sociodemographics, clinical presentation, and hospitalization outcome data. Blood, nasal\/oropharyngeal swabs and tracheal aspirate samples were collected based on the patient's clinical presentation and transported to the Kenyatta National Hospital microbiology laboratory for immediate processing following the standard bacteriological procedures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found at least one bacterial infection in 44.2% (53\/120) of the patients sampled, with a 31.7% mortality rate. Pathogens were mainly from the upper respiratory tract (62.7%, 42\/67), with gram-negative bacteria dominating (73.1%, 49\/67). Males were about three times more likely to acquire bacterial infection (<jats:italic>p<\/jats:italic>\u2009=\u20090.015). Those aged 25 to 44\u00a0years (p\u2009=\u20090.009), immunized against SARS-CoV-2 (p\u2009=\u20090.027), and admitted to the infectious disease unit ward (p\u2009=\u20090.031) for a short length of stay (0\u20135\u00a0days, p\u2009&lt;\u20090.001) were more likely to have a positive outcome. Multidrug-resistant isolates were the majority (64.3%, 46\/67), mainly gram-negative bacteria (69.6%, 32\/46). The predominant multidrug-resistant phenotypes were in\u00a0<jats:italic>Enterococcus cloacae<\/jats:italic>\u00a0(42.9%, 3\/7),\u00a0<jats:italic>Klebsiella pneumonia<\/jats:italic>\u00a0(25%, 4\/16), and\u00a0<jats:italic>Escherichia coli<\/jats:italic>\u00a0(40%, 2\/5).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings highlight a high prevalence of multidrug-resistant bacterial infections in severely ill COVID-19 patients, with male gender as a risk factor for bacterial infection. Elderly Patients, non-SARS-CoV-2 vaccination, intensive care unit admission, and long length of hospital stay were associated with poor outcomes. There is a need to emphasize strict adherence to infection and prevention at KNH-IDU and antimicrobial stewardship in line with local and global AMR control action plans.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07885-3","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T10:18:15Z","timestamp":1669198695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Multidrug resistant bacterial infections in severely ill COVID-19 patients admitted in a national referral and teaching hospital, Kenya"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9698-6972","authenticated-orcid":false,"given":"Jeniffer Munyiva","family":"Mutua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Mwaniki","family":"Njeru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1221-3735","authenticated-orcid":false,"given":"Abednego Moki","family":"Musyoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"issue":"13","key":"7885_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239\u201342.","journal-title":"JAMA"},{"key":"7885_CR2","unstructured":"\u201c41e3b7eb21b2fc547b8773fb1d871add874da063@covid19.who.int.\u201d [Online]. https:\/\/covid19.who.int\/region\/afro\/country\/ke. Accessed 22 June 2022."},{"key":"7885_CR3","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2147\/TCRM.S87789","volume":"11","author":"MA Hendaus","year":"2015","unstructured":"Hendaus MA, Jomha FA, Alhammadi AH. Virus-induced secondary bacterial infection: a concise review. Ther Clin Risk Manag. 2015;11:1265\u201371. https:\/\/doi.org\/10.2147\/TCRM.S87789.","journal-title":"Ther Clin Risk Manag"},{"issue":"20","key":"7885_CR4","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa0908481","volume":"361","author":"SA Webb","year":"2009","unstructured":"Webb SA, Pettil\u00e4 V, Seppelt I, Bellomo R, Bailey M, Cooper DJ. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361(20):1925.","journal-title":"N Engl J Med"},{"issue":"1","key":"7885_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1164\/rccm.200909-1420OC","volume":"181","author":"T Mauad","year":"2010","unstructured":"Mauad T, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2010;181(1):72\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"7885_CR6","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","volume":"26","author":"BJ Langford","year":"2020","unstructured":"Langford BJ, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"7885_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2353\/ajpath.2010.100115","volume":"177","author":"W-J Shieh","year":"2010","unstructured":"Shieh W-J, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol. 2010;177(1):166\u201375.","journal-title":"Am J Pathol"},{"issue":"17","key":"7885_CR8","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1001\/jama.2009.1496","volume":"302","author":"A Kumar","year":"2009","unstructured":"Kumar A, et al. Critically Ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302(17):1872\u20139. https:\/\/doi.org\/10.1001\/jama.2009.1496.","journal-title":"JAMA"},{"issue":"1","key":"7885_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1164\/rccm.201001-0037oc","volume":"182","author":"E Estenssoro","year":"2010","unstructured":"Estenssoro E, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med. 2010;182(1):41\u20138. https:\/\/doi.org\/10.1164\/rccm.201001-0037oc.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"7885_CR10","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1097\/CCM.0b013e3182416f23","volume":"40","author":"TW Rice","year":"2012","unstructured":"Rice TW, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40(5):1487\u201398. https:\/\/doi.org\/10.1097\/CCM.0b013e3182416f23.","journal-title":"Crit Care Med"},{"key":"7885_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3548-0","volume":"18","author":"CR Macintyre","year":"2018","unstructured":"Macintyre CR, et al. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09. BMC Infect Dis. 2018;18:1\u201318.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"7885_CR12","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1017\/ice.2020.322","volume":"41","author":"A Hazra","year":"2020","unstructured":"Hazra A, Collison M, Pisano J, Kumar M, Oehler C, Ridgway JP. Coinfections with SARS-CoV-2 and other respiratory pathogens. Infect Control Hosp Epidemiol. 2020;41(10):1228\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"7885_CR13","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","volume":"26","author":"S Hughes","year":"2020","unstructured":"Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26(10):1395\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"7885_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198005","volume":"285","author":"X Zhu","year":"2020","unstructured":"Zhu X, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285: 198005.","journal-title":"Virus Res"},{"key":"7885_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.784130\/full","author":"S Pourajam","year":"2022","unstructured":"Pourajam S, et al. Secondary bacterial infection and clinical characteristics in patients with COVID-19 admitted to two intensive care units of an academic hospital in iran during the first wave of the pandemic. Front Cell Infect Microbiol. 2022. https:\/\/doi.org\/10.3389\/fcimb.2022.784130\/full.","journal-title":"Front Cell Infect Microbiol"},{"issue":"10229","key":"7885_CR16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"10","key":"7885_CR17","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1093\/cid\/ciaa1239","volume":"72","author":"VM Vaughn","year":"2021","unstructured":"Vaughn VM, et al. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a multi-hospital cohort study. Clin Infect Dis. 2021;72(10):e533\u201341.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"7885_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s15010-020-01553-x","volume":"49","author":"A Elabbadi","year":"2021","unstructured":"Elabbadi A, Turpin M, Gerotziafas GT, Teulier M, Voiriot G, Fartoukh M. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia. Infection. 2021;49(3):559\u201362.","journal-title":"Infection"},{"issue":"4","key":"7885_CR19","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/jac\/dkaa530","volume":"76","author":"M Falcone","year":"2021","unstructured":"Falcone M, et al. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J Antimicrob Chemother. 2021;76(4):1078\u201384.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"7885_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-92220-0","volume":"11","author":"N Shafran","year":"2021","unstructured":"Shafran N, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep. 2021;11(1):1\u20138.","journal-title":"Sci Rep"},{"issue":"1","key":"7885_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/tmi.13504","volume":"26","author":"AA Anjorin","year":"2021","unstructured":"Anjorin AA, et al. Comorbidities and the COVID-19 pandemic dynamics in Africa. Trop Med Int Heal. 2021;26(1):2\u201313.","journal-title":"Trop Med Int Heal"},{"key":"7885_CR22","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.supp.2020.35.23713","author":"CJ Iwu","year":"2020","unstructured":"Iwu CJ, Jordan P, Jaja IF, Iwu CD, Wiysonge CS. Treatment of COVID-19: implications for antimicrobial resistance in Africa. Pan Afr Med J. 2020. https:\/\/doi.org\/10.11604\/pamj.supp.2020.35.23713.","journal-title":"Pan Afr Med J."},{"issue":"8","key":"7885_CR23","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/microorganisms9081773","volume":"9","author":"D Pasero","year":"2021","unstructured":"Pasero D, Cossu AP, Terragni P. Multi-drug resistance bacterial infections in critically ill patients admitted with COVID-19. Microorganisms. 2021;9(8):1773.","journal-title":"Microorganisms"},{"issue":"3","key":"7885_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/idr14030042","volume":"14","author":"A Marino","year":"2022","unstructured":"Marino A, et al. Corynebacterium striatum bacteremia during SARS-CoV2 infection: case report, literature review, and clinical considerations. Infect Dis Rep. 2022;14(3):383\u201390.","journal-title":"Infect Dis Rep"},{"issue":"5","key":"7885_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475\u201381.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"7885_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/antibiotics10060745","volume":"10","author":"W Cong","year":"2021","unstructured":"Cong W, Poudel AN, Alhusein N, Wang H, Yao G, Lambert H. Antimicrobial use in COVID-19 patients in the first phase of the SARS-CoV-2 pandemic: a scoping review. Antibiotics. 2021;10(6):745.","journal-title":"Antibiotics"},{"key":"7885_CR27","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/IDR.S234610","volume":"12","author":"P Dadgostar","year":"2019","unstructured":"Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"7885_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jhin.2019.02.019","volume":"101","author":"M Courtenay","year":"2019","unstructured":"Courtenay M, Castro-Sanchez E, Fitzpatrick M, Gallagher R, Lim R, Morris G. Tackling antimicrobial resistance 2019\u20132024\u2013the UK\u2019s five-year national action plan. J Hosp Infect. 2019;101(4):426\u20137.","journal-title":"J Hosp Infect"},{"key":"7885_CR29","unstructured":"Word Health Organization. Turning plans into action for antimicrobial resistance. Word Health Organization, 2019; 1\u201329, [Online]. https:\/\/www.eusaferhealthcare.eu\/wp-content\/uploads\/amr-turning-plans-into-action-working-paper-march-2019-min.pdf. Accessed 22 June 2022."},{"key":"7885_CR30","unstructured":"OMS. Global action plan on antimicrobial resistance. World Heal Organ 2017:1\u201328. https:\/\/www.amcra.be\/swfiles\/files\/WHO%20actieplan_90.pdf."},{"key":"7885_CR31","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.2147\/IDR.S299774","volume":"14","author":"S Vijay","year":"2021","unstructured":"Vijay S, et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect Drug Resist. 2021;14:1893\u2013903. https:\/\/doi.org\/10.2147\/IDR.S299774.","journal-title":"Infect Drug Resist"},{"key":"7885_CR32","unstructured":"Weistein M, et al. M100 Performance standards for antimicrobial. 2021.\nhttps:\/\/mail.google.com\/mail\/u\/0?ui=2&ik=28b551ac93&attid=0.1&permmsgid=msgf:1749199266262974310&th=184667770afa7f66&view=att&disp=inline&realattid=f_kobeenmn0."},{"issue":"3","key":"7885_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jinf.2014.10.004","volume":"70","author":"I Martin-Loeches","year":"2015","unstructured":"Martin-Loeches I, et al. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organi. J Infect. 2015;70(3):213\u201322. https:\/\/doi.org\/10.1016\/j.jinf.2014.10.004.","journal-title":"J Infect"},{"issue":"4","key":"7885_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3343\/alm.2020.40.4.306","volume":"40","author":"JD Uwizeyimana","year":"2020","unstructured":"Uwizeyimana JD, Kim D, Lee H, Byun JH, Yong D. Determination of colistin resistance by simple disk diffusion test using modified mueller-hinton agar. Ann Lab Med. 2020;40(4):306\u201311. https:\/\/doi.org\/10.3343\/alm.2020.40.4.306.","journal-title":"Ann Lab Med"},{"key":"7885_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4065603","author":"S Basak","year":"2016","unstructured":"Basak S, Singh P, Rajurkar M. Multidrug resistant and extensively drug resistant bacteria: a study. J Pathog. 2016. https:\/\/doi.org\/10.1155\/2016\/4065603.","journal-title":"J Pathog."},{"issue":"3","key":"7885_CR36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jac\/dkaa475","volume":"76","author":"L Wang","year":"2021","unstructured":"Wang L, et al. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London. J Antimicrob Chemother. 2021;76(3):796\u2013803.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"7885_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-05877-3","volume":"21","author":"L Puzniak","year":"2021","unstructured":"Puzniak L, et al. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19. BMC Infect Dis. 2021;21(1):1\u20139.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"7885_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272375","volume":"17","author":"FS Alshaikh","year":"2022","unstructured":"Alshaikh FS, Godman B, Sindi ON, Seaton RA, Kurdi A. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis. PLoS ONE. 2022;17(8): e0272375.","journal-title":"PLoS ONE"},{"issue":"1","key":"7885_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13613-020-00736-x","volume":"10","author":"D Contou","year":"2020","unstructured":"Contou D, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care. 2020;10(1):119. https:\/\/doi.org\/10.1186\/s13613-020-00736-x.","journal-title":"Ann Intensive Care"},{"key":"7885_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-micro-091014-104209","volume":"69","author":"SJ Siegel","year":"2015","unstructured":"Siegel SJ, Weiser JN. Mechanisms of bacterial colonization of the respiratory tract. Annu Rev Microbiol. 2015;69:425\u201344. https:\/\/doi.org\/10.1146\/annurev-micro-091014-104209.","journal-title":"Annu Rev Microbiol"},{"issue":"4","key":"7885_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5501\/wjv.v10.i4.168","volume":"10","author":"NK Saeed","year":"2021","unstructured":"Saeed NK, Al-Khawaja S, Alsalman J, Almusawi S, Albalooshi NA, Al-Biltagi M. Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain. World J Virol. 2021;10(4):168\u201381. https:\/\/doi.org\/10.5501\/wjv.v10.i4.168.","journal-title":"World J Virol"},{"key":"7885_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/biology10090822","author":"I Stefanini","year":"2021","unstructured":"Stefanini I, De Renzi G, Foddai E, Cordani E, Mognetti B. Profile of bacterial infections in COVID-19 patients: antimicrobial resistance in the time of SARS-CoV-2. Biology. 2021. https:\/\/doi.org\/10.3390\/biology10090822.","journal-title":"Biology"},{"issue":"1","key":"7885_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","volume":"27","author":"C Garcia-Vidal","year":"2021","unstructured":"Garcia-Vidal C, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.041.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"7885_CR44","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1016\/S2666-5247(21)00090-2","volume":"2","author":"CD Russell","year":"2021","unstructured":"Russell CD, et al. Co-infections, secondary infections, and antimicrobial usage in hospitalised patients with COVID-19 from the ISARIC WHO CCP-UK study: a prospective, multicentre cohort study. Microbe. 2021;2(8):e354\u201365. https:\/\/doi.org\/10.1016\/S2666-5247(21)00090-2.","journal-title":"Microbe"},{"issue":"9","key":"7885_CR45","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.3390\/ijerph19095270","volume":"19","author":"KB Said","year":"2022","unstructured":"Said KB, et al. COVID-19 clinical profiles and fatality rates in hospitalized patients reveal case aggravation and selective co-infection by limited gram-negative bacteria. Int J Environ Res Public Health. 2022;19(9):5270.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"7885_CR46","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/jmv.26441","volume":"93","author":"A Goncalves Mendes Neto","year":"2021","unstructured":"Goncalves Mendes Neto A, et al. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J Med Virol. 2021;93(3):1489\u201395.","journal-title":"J Med Virol"},{"issue":"1","key":"7885_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12915-019-0703-z","volume":"17","author":"C Kumpitsch","year":"2019","unstructured":"Kumpitsch C, Koskinen K, Sch\u00f6pf V, Moissl-Eichinger C. The microbiome of the upper respiratory tract in health and disease. BMC Biol. 2019;17(1):1\u201320.","journal-title":"BMC Biol"},{"issue":"10","key":"7885_CR48","doi-asserted-by":"publisher","first-page":"e00283","DOI":"10.1128\/iai.00283-22","volume":"90","author":"SP Dias","year":"2022","unstructured":"Dias SP, Brouwer MC, van de Beek D. Sex and gender differences in bacterial infections. Infect Immun. 2022;90(10):e00283-e322.","journal-title":"Infect Immun"},{"issue":"7","key":"7885_CR49","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s42399-020-00341-w","volume":"2","author":"GM Bwire","year":"2020","unstructured":"Bwire GM. Coronavirus: why men are more vulnerable to Covid-19 than women? SN Compr Clin Med. 2020;2(7):874\u20136. https:\/\/doi.org\/10.1007\/s42399-020-00341-w.","journal-title":"SN Compr Clin Med"},{"issue":"11","key":"7885_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241824","volume":"15","author":"FK Ho","year":"2020","unstructured":"Ho FK, et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE. 2020;15(11): e0241824.","journal-title":"PLoS ONE"},{"key":"7885_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.757459","author":"H Zhang","year":"2021","unstructured":"Zhang H, et al. Age-related risk factors and complications of patients with COVID-19: a population-based retrospective study. Front Med. 2021. https:\/\/doi.org\/10.3389\/fmed.2021.757459.","journal-title":"Front Med"},{"issue":"9","key":"7885_CR52","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1093\/cid\/ciaa1012","volume":"72","author":"L Kim","year":"2021","unstructured":"Kim L, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET). Clin Infect Dis. 2021;72(9):e206\u201314.","journal-title":"Clin Infect Dis"},{"key":"7885_CR53","doi-asserted-by":"publisher","DOI":"10.1086\/432007","author":"SM Opal","year":"2005","unstructured":"Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005. https:\/\/doi.org\/10.1086\/432007.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7885_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-022-07657-z","volume":"22","author":"M Stepanova","year":"2022","unstructured":"Stepanova M, et al. The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19. BMC Infect Dis. 2022;22(1):1\u201311.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"7885_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/idr14030041","volume":"14","author":"M Ceccarelli","year":"2022","unstructured":"Ceccarelli M, et al. Bacterial and fungal co-infections and superinfections in a cohort of COVID-19 patients: real-life data from an italian third level hospital. Infect Dis Rep. 2022;14(3):372\u201382. https:\/\/doi.org\/10.3390\/idr14030041.","journal-title":"Infect Dis Rep"},{"issue":"1","key":"7885_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-017-0191-3","volume":"16","author":"L Xu","year":"2017","unstructured":"Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):1\u201312.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"7885_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.matpr.2021.05.344","author":"OB Ahmed","year":"2021","unstructured":"Ahmed OB, Asghar AH, Bahwerth FS. Increasing frequency of aminoglycoside-resistant Klebsiella pneumoniae during the era of pandemic COVID-19. Mater Today Proc. 2021. https:\/\/doi.org\/10.1016\/j.matpr.2021.05.344.","journal-title":"Mater Today Proc"},{"issue":"1","key":"7885_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ajic.2021.09.018","volume":"50","author":"M Polly","year":"2022","unstructured":"Polly M, de Almeida BL, Lennon RP, Cort\u00eas MF, Costa SF, Guimar\u00e3es T. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil. Am J Infect Control. 2022;50(1):32\u20138.","journal-title":"Am J Infect Control"},{"issue":"45","key":"7885_CR59","doi-asserted-by":"publisher","first-page":"2001886","DOI":"10.2807\/1560-7917.ES.2020.25.45.2001886","volume":"25","author":"DL Monnet","year":"2020","unstructured":"Monnet DL, Harbarth S. Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance? Eurosurveillance. 2020;25(45):2001886.","journal-title":"Eurosurveillance"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07885-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07885-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07885-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T10:18:34Z","timestamp":1669198714000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07885-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7885"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07885-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Kenyatta National Hospital-University of Nairobi Ethics Review committee (protocol Number: P236\/04\/21) and was performed in accordance with Helsinki declaration. Participant were required to give informed written consent through a close relative or legal representative. Parents and\/or guardians gave permission on behalf of their children after the study was explained to them in English, or Swahili. Personal Identification Number (PIN) unique to each patient was assigned to all samples collected for anonymity and the information collected was confidential. There were no monetary gains for the study participants, and no penalties for those who declined to participate. Approval to carry out the study was sought from the hospital management (Ref: KNH\/DLM\/60\/VOL.11\/110) and National Commission for Science, Technology and Innovation (License No: NACOSTI\/P\/22\/18891).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"877"}}